iTeos Therapeutics, Inc. (NASDAQ:ITOS) Receives $15.86 Consensus Price Target from Brokerages
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) has been given an average recommendation of “Hold” by the seven research firms that are currently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12-month price […]
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) has been given an average recommendation of “Hold” by the seven research firms that are currently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12-month price […]
